Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline

Henry A. Nasrallah; Jonathan M. Meyer; Donald Goff; Joseph P. McEvoy; Sonia M. Davis; T. Scott Stroup; Jeffrey A. Lieberman

doi:10.1016/j.schres.2006.06.026

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline

Authors: Henry A. Nasrallah, Jonathan M. Meyer, Donald Goff, Joseph P. McEvoy, Sonia M. Davis, T. Scott Stroup, Jeffrey A. Lieberman - Schizophrenia Research 2006 cited by 558

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline | Litlas